Jun. 8 at 5:39 PM
$PPBT
If we are thinking logic here instead of dreaming….. Having a non dilutive Out-licensing deal as an option and we take in consideration that the company that want to license all 3 drugs in the pipeline have to pay everything for the further development of the drugs. Then the deal might be better than a BO ( No. You are right, i’m not on the same level as Smitty ! ) With a
$15 million upfront and a
$500 million CVR if the drugs succeed and reach the market.
Yes, that would be realistic because Purple have absolutely no leverage for negotiations on the price tag !
.. But, with those
$15 million the MC would be high enough for the 1.2 million warrants to be exercised with profit for the Tutes ! And the company would end up with around
$30 million in cash.
After the hype and spike this SHELL company will have a SP around
$11 and around 2.4 million outstanding ADS shares.
